Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

11,881 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Helical tomotherapy for chemo-refractory multiple liver metastases.
Takaoka T, Shibamoto Y, Murai T, Kobayashi M, Sugie C, Manabe Y, Kondo T, Okazaki D, Yamada Y, Torii A. Takaoka T, et al. Among authors: kobayashi m. Cancer Med. 2019 Dec;8(18):7594-7602. doi: 10.1002/cam4.2651. Epub 2019 Oct 29. Cancer Med. 2019. PMID: 31663296 Free PMC article.
Dendritic cell-based immunotherapy targeting synthesized peptides for advanced biliary tract cancer.
Kobayashi M, Sakabe T, Abe H, Tanii M, Takahashi H, Chiba A, Yanagida E, Shibamoto Y, Ogasawara M, Tsujitani S, Koido S, Nagai K, Shimodaira S, Okamoto M, Yonemitsu Y, Suzuki N, Nagaya M; DC-vaccine study group at the Japan Society of Innovative Cell Therapy (J-SICT). Kobayashi M, et al. J Gastrointest Surg. 2013 Sep;17(9):1609-17. doi: 10.1007/s11605-013-2286-2. Epub 2013 Jul 20. J Gastrointest Surg. 2013. PMID: 23877328
Prognostic factors related to add-on dendritic cell vaccines on patients with inoperable pancreatic cancer receiving chemotherapy: a multicenter analysis.
Kobayashi M, Shimodaira S, Nagai K, Ogasawara M, Takahashi H, Abe H, Tanii M, Okamoto M, Tsujitani S, Yusa S, Ishidao T, Kishimoto J, Shibamoto Y, Nagaya M, Yonemitsu Y; DC Vaccine Study Group at the Japan Society of Innovative Cell Therapy (J-SICT). Kobayashi M, et al. Cancer Immunol Immunother. 2014 Aug;63(8):797-806. doi: 10.1007/s00262-014-1554-7. Epub 2014 Apr 29. Cancer Immunol Immunother. 2014. PMID: 24777613 Free PMC article.
The feasibility and clinical effects of dendritic cell-based immunotherapy targeting synthesized peptides for recurrent ovarian cancer.
Kobayashi M, Chiba A, Izawa H, Yanagida E, Okamoto M, Shimodaira S, Yonemitsu Y, Shibamoto Y, Suzuki N, Nagaya M; DC-vaccine study group at the Japan Society of Innovative Cell Therapy (J-SICT). Kobayashi M, et al. J Ovarian Res. 2014 May 7;7:48. doi: 10.1186/1757-2215-7-48. J Ovarian Res. 2014. PMID: 25298213 Free PMC article.
Therapeutic effect of intratumoral injections of dendritic cells for locally recurrent gastric cancer: a case report.
Kobayashi M, Sakabe T, Chiba A, Nakajima A, Okamoto M, Shimodaira S, Yonemitsu Y, Shibamoto Y, Suzuki N, Nagaya M; DC-vaccine study group at the Japan Society of Innovative Cell Therapy (J-SICT). Kobayashi M, et al. World J Surg Oncol. 2014 Dec 19;12:390. doi: 10.1186/1477-7819-12-390. World J Surg Oncol. 2014. PMID: 25526950 Free PMC article.
Lung adenocarcinoma may be a more susceptive subtype to a dendritic cell-based cancer vaccine than other subtypes of non-small cell lung cancers: a multicenter retrospective analysis.
Takahashi H, Shimodaira S, Ogasawara M, Ota S, Kobayashi M, Abe H, Morita Y, Nagai K, Tsujitani S, Okamoto M, Suzuki Y, Nakanishi Y, Yonemitsu Y; DC Vaccine Study Group at the Japanese Society of Immunotherapy and Cell Therapy. Takahashi H, et al. Among authors: kobayashi m. Cancer Immunol Immunother. 2016 Sep;65(9):1099-111. doi: 10.1007/s00262-016-1872-z. Epub 2016 Jul 22. Cancer Immunol Immunother. 2016. PMID: 27448677 Free PMC article.
11,881 results
You have reached the last available page of results. Please see the User Guide for more information.